Special Panel: Edward Dowd, Kelly Brown and Jessica Rose

<p>We’ve reached a tipping point in evaluating the Covid-19 vaccines as still more studies indicate it is time to be worried - the efficacy is crashing and adverse reactions are gaining credibility. Also — excess death numbers began climbing when the jabs were mandated and although no one can make a direct link — the time has come to evaluate a possible connection. Trish speaks to a special panel — including former hedge fund manager Edward Dowd and investor Kelly Brown who both say the numbers are a significant and independent researcher, and Jessica Rose who has been deep diving into the adverse reaction data.</p>